Vedolizumab

Trade Name: 
Entyvio
Manufacturer/Distributor: 
Takeda Canada
Classification: 
Immunosuppressive agent
ATC Class: 
L04AA - selective immunosuppressant
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2015/01/29
Date Marketed in Canada (yyyy/mm/dd): 
2015/04/21
Presentation: 
Powder for infusion: 300 mg. DIN: 02436841
Comments: 
Monoclonal antibody for treatment of adult patients with moderate to severely active ulcerative colitis who have had an inadequate response to conventional therapy or infliximab.